Trapping the Monomer of a Non-amyloidogenic Variant of Transthyretin

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Biological Chemistry

• Publication date

  2009-01-16

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1074/jbc.M807100200PMID 18984591
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hormone delivery systems to the brain-transthyretin.

  2009cited by this paper
• Human-Murine Transthyretin Heterotetramers Are Kinetically Stable and Non-amyloidogenic

  2008cited by this paper
• Intriguing nucleic-acid-binding features of mammalian prion protein.

  2008cited by this paper
• The biological and chemical basis for tissue-selective amyloid disease.

  2005cited by this paper
• The pathway by which the tetrameric protein transthyretin dissociates.

  2005cited by this paper
• Liver transplantation and new therapeutic approaches for familial amyloidotic polyneuropathy (FAP)

  2005cited by this paper
• New insights into the mechanisms of protein misfolding and aggregation in amyloidogenic diseases derived from pressure studies.

  2004cited by this paper
• Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative.

  2004cited by this paper
• Hydration and packing are crucial to amyloidogenesis as revealed by pressure studies on transthyretin variants that either protect or worsen amyloid disease.

  2003cited by this paper
• Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling.

  2003cited by this paper
• Tabulation of human transthyretin (TTR) variants, 2003

  2003cited by this paper
• Dissociation of amyloid fibrils of α-synuclein and transthyretin by pressure reveals their reversible nature and the formation of water-excluded cavities

  2003cited by this paper
• Energetic Characteristics of the New Transthyretin Variant A25T May Explain Its Atypical Central Nervous System Pathology

  2003cited by this paper
• Androgenetic alopecia: pathogenesis and potential for therapy

  2002cited by this paper
• Hereditary transthyretin amyloidosis: molecular basis and therapeutical strategies

  2002cited by this paper
• Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity

  2002cited by this paper
• Synthesis, structure, and activity of diclofenac analogues as transthyretin amyloid fibril formation inhibitors.

  2002cited by this paper
• Revisiting volume changes in pressure-induced protein unfolding.

  2002cited by this paper
• Decreased thermodynamic stability as a crucial factor for familial amyloidotic polyneuropathy.

  2002cited by this paper
• Transthyretin: a review from a structural perspective

  2001cited by this paper
• Capture of a Dimeric Intermediate during Transthyretin Amyloid Formation*

  2001cited by this paper
• An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured.

  2001cited by this paper
• Tetramer Dissociation and Monomer Partial Unfolding Precedes Protofibril Formation in Amyloidogenic Transthyretin Variants*

  2001cited by this paper
• Trans-Suppression of Misfolding in an Amyloid Disease

  2001cited by this paper
• Transthyretin stability as a key factor in amyloidogenesis: X-ray analysis at atomic resolution.

  2001cited by this paper
• Rational design of potent human transthyretin amyloid disease inhibitors

  2000cited by this paper
• The preaggregated state of an amyloidogenic protein: hydrostatic pressure converts native transthyretin into the amyloidogenic state.

  2000cited by this paper
• The beta-slip: a novel concept in transthyretin amyloidosis.

  2000cited by this paper
• The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways.

  1998cited by this paper
• Thyroxine binding to transthyretin Met 119

  1997cited by this paper
• Comparative stability and clearance of [Met30]transthyretin and [Met119]transthyretin.

  1997cited by this paper
• Thyroxine binding to transthyretin Met 119. Comparative studies of different heterozygotic carriers and structural analysis.

  1997cited by this paper
• Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid.

  1997cited by this paper
• The amyloidogenic potential of transthyretin variants correlates with their tendency to aggregate in solution

  1997cited by this paper
• The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.

  1996cited by this paper
• Comparison of lethal and nonlethal transthyretin variants and their relationship to amyloid disease.

  1995cited by this paper
• Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro.

  1992cited by this paper
• Fibril in senile systemic amyloidosis is derived from normal transthyretin.

  1990cited by this paper
• Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation.

  1989cited by this paper
• Reaction volume of protonic ionization for buffering agents. Prediction of pressure dependence of pH and pOH

  1987cited by this paper
• Pressure-induced reversible dissociation of enolase.

  1981cited by this paper
• 4,4'-Bis (1-anilinonaphthalene 8-sulfonate) (bis-ANS): a new probe of the active site of myosin.

  1977cited by this paper
• Negative cooperativity in the binding of thyroxine to human serum prealbumin. Preparation of tritium-labeled 8-anilino-1-naphthalenesulfonic acid.

  1975cited by this paper
• Thermodynamics of protein denaturation. Effect of pressu on the denaturation of ribonuclease A.

  1970cited by this paper

• Structural and thermodynamic characterization of a highly amyloidogenic dimer of transthyretin involved in a severe cardiomyopathy

  2024cites this paper
• Connection between MHC class II binding and aggregation propensity: The antigenic peptide 10 of Paracoccidioides brasiliensis as a benchmark study

  2023cites this paper
• JM-20, a Benzodiazepine-Dihydropyridine Hybrid Molecule, Inhibits the Formation of Alpha-Synuclein-Aggregated Species

  2022cites this paper
• Transthyretin Misfolding, A Fatal Structural Pathogenesis Mechanism

  2021cites this paper
• Disease-associated mutations impacting BC-loop flexibility trigger long-range transthyretin tetramer destabilization and aggregation

  2021cites this paper
• THE IMS PARADOX: A PERSPECTIVE ON STRUCTURAL ION MOBILITY-MASS SPECTROMETRY.

  2020cites this paper
• Cavity filling mutations at the thyroxine-binding site dramatically increase transthyretin stability and prevent its aggregation

  2017cites this paper
• Impact of Variant Reclassification in the Clinical Setting of Cardiovascular Genetics

  2017cites this paper
• Alta Pressão: Uma Nova Dimensão para o Entendimento de Estruturas e Dinâmicas de Moléculas Biológicas e suas Aplicações

  2015cites this paper
• Quantification of Transthyretin Kinetic Stability in Human Plasma Using Subunit Exchange

  2014cites this paper
• High-pressure chemical biology and biotechnology.

  2014cites this paper
• Activated microglia mediate synapse loss and short-term memory deficits in a mouse model of transthyretin-related oculoleptomeningeal amyloidosis

  2013cites this paper
• Structure-Based Analysis of A19D, a Variant of Transthyretin Involved in Familial Amyloid Cardiomyopathy

  2013cites this paper
• Pressure-temperature folding landscape in proteins involved in neurodegenerative diseases and cancer.

  2013cites this paper
• [New trends in the treatment of amyloidosis].

  2012cites this paper
• Specific disruption of transthyretin(105-115) fibrilization using "stabilizing" inhibitors of transthyretin amyloidogenesis.

  2012cites this paper
• Amyloid Fibrils Trigger the Release of Neutrophil Extracellular Traps (NETs), Causing Fibril Fragmentation by NET-associated Elastase*

  2012cites this paper
• Strategies for Inhibiting Protein Aggregation: Therapeutic Approaches to Protein-Aggregation Diseases

  2012cites this paper
• Transthyretin amyloidosis and the kidney.

  2012cites this paper
• Characterization of the unfolding process of the tetrameric and dimeric forms of Cratylia mollis seed lectin (CRAMOLL 1): effects of natural fragmentation on protein stability.

  2011cites this paper
• High hydrostatic pressure and biology: a brief history

  2011cites this paper
• Characterization of the interaction of β-amyloid with transthyretin monomers and tetramers.

  2010cites this paper
• Elastic incoherent neutron scattering as a probe of high pressure induced changes in protein flexibility.

  2010cites this paper
• Identification of a novel ligand binding motif in the transthyretin channel.

  2010cites this paper
• Mechanisms of Molecular Recognition: Structural Characteristics of Transthyretin Ligand Interactions

  2009cites this paper
• Ligand Binding and Hydration in Protein Misfolding: Insights from Studies of Prion and p53 Tumor Suppressor Proteins†

  2009cites this paper